Forte Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,139
Closed -$205K 239
2023
Q4
$205K Buy
+1,139
New +$177K 0.03% 222
2022
Q2
Sell
-1,029
Closed -$273K 222
2022
Q1
$273K Hold
1,029
0.03% 198
2021
Q4
$273K Hold
1,029
0.03% 198
2021
Q3
$297K Hold
1,029
0.04% 181
2021
Q2
$205K Hold
1,029
0.03% 213
2021
Q1
$200K Buy
+1,029
New +$211K 0.03% 205

Other funds holding RGEN

Forte Capital's RGEN Position: Q1 2024 in Review

Forte Capital sold out of Repligen (RGEN) in Q1 2024, closing a stake of 1,139 shares — an estimated $205K sold.

Forte Capital first reported a position in RGEN in Q1 2021 and held it in 6 quarters. The position peaked at $297K in Q3 2021. 487 funds tracked by Wall St. Rank hold RGEN as of Q1 2024.

  • Forte Capital reported no remaining Repligen position as of Q1 2024 after selling out during the quarter.
  • Forte Capital sold 1,139 Repligen shares in Q1 2024, an estimated $205K.
  • Forte Capital first reported a position in Repligen in Q1 2021 and held it in 6 quarters.
  • Forte Capital's Repligen position peaked at $297K in Q3 2021.
  • 487 funds tracked by Wall St. Rank held Repligen as of Q1 2024.

Based on Forte Capital's 13F filing for Q1 2024, filed 14 May 2024.